| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734345 | Surgery | 2017 | 6 Pages |
Abstract
Dr Egeland is senior director of business development and licensing in the Early Technologies business unit of the Minimally Invasive Therapies Group at Medtronic.Mr Rapp is an associate consultant at Pharmagellan, a biotech consultancy.Dr David is the founder and managing director of Pharmagellan.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Ryan D. MD, PhD, MBA, Zachary MA, Frank S. MD, PhD,